Gottlieb, A., Blauvelt, A., Tha?i, D., Poulin, Y., Brock, F., Arendt, C., Boehnlein, M. and Reich, K. (2020) “Reductions in Absolute PASI Over 144 Weeks of Treatment with Certolizumab Pegol in Patients with Plaque Psoriasis: Pooled Analysis from Two Phase 3 Trials (CIMPASI-1 and CIMPASI-2)”, SKIN The Journal of Cutaneous Medicine, 4(6), p. s84. doi: 10.25251/skin.4.supp.84.